Bioharvest Sciences Cash Flow Statement (2023-2025) | BHST

Cash Flow Statement Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income 2.85M1.73M7.24M-6.58M-0.69M-2.69M-2.95M-2.34M-4.08M-2.51M
Share-based Compensation 0.12M0.13M0.13M0.20M0.13M0.15M0.13M
Gains from Sales and Divestitures 8.57M
Cash from Operations -0.99M-2.99M-1.58M-0.96M-1.76M-2.39M-1.43M-1.46M-2.09M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.22M0.22M0.20M0.36M0.35M0.34M0.40M0.41M0.39M
Change in Working Capital
Change in Receivables -0.05M-0.17M0.05M-0.15M-0.26M0.05M-0.36M-0.14M0.24M
Change in Inventory -0.08M-0.39M-0.21M0.11M-0.62M-0.47M-0.36M-0.12M-0.31M
Change in Accured Expenses 0.82M-0.12M-0.13M0.37M1.10M-0.30M0.56M0.84M0.06M
Other Working Capital Changes 0.06M0.22M-0.14M-0.55M
Investing Activities
Capital Expenditures -0.44M-0.29M-0.22M-1.71M-0.51M-0.39M-0.68M-0.59M-0.42M
Cash from Investing Activities -0.44M-0.29M-0.22M-1.93M-0.47M-0.40M-0.68M-0.59M-0.42M
Financing Activities
Cash from Financing Activities 1.18M7.01M-0.12M4.61M-0.16M2.45M3.12M2.39M9.74M
Additional items
Exchange Rate Effect -0.00M0.07M-0.00M0.02M-0.01M-0.04M-0.00M-0.01M0.02M
Change in Cash -0.25M3.72M-1.92M1.72M-2.40M-0.34M1.01M0.34M7.22M
Free Cash Flow -0.56M-2.70M-1.36M0.75M-1.25M-2.00M-0.74M-0.86M-1.67M
Net Cash Flow -0.25M3.72M-1.92M1.72M-2.40M-0.34M1.01M0.34M7.22M